DF
IDXX icon

DecisionPoint Financial’s Idexx Laboratories IDXX Stock Holding History

DecisionPoint Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$562 Hold
1
– – ﹤0.01% 458
2025
Q4 		$677 Hold
1
– – ﹤0.01% 470
2025
Q3 		$621 Hold
1
– – ﹤0.01% 413
2025
Q2 		$543 Buy
+1
New +$478 ﹤0.01% 427

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DecisionPoint Financial's IDXX Position: Q1 2026 in Review

DecisionPoint Financial held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1 share worth $562. The position accounts for ﹤0.01% of the portfolio, ranked #458.

DecisionPoint Financial first reported a position in IDXX in Q2 2025 and has held it in 4 quarters since. The position peaked at $677 in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • DecisionPoint Financial held 1 share of Idexx Laboratories worth $562 as of Q1 2026.
  • DecisionPoint Financial left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of DecisionPoint Financial's portfolio in Q1 2026, its #458 holding.
  • DecisionPoint Financial first reported a position in Idexx Laboratories in Q2 2025 and has held it in 4 quarters since.
  • DecisionPoint Financial's Idexx Laboratories position peaked at $677 in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on DecisionPoint Financial's 13F filing for Q1 2026, filed 6 May 2026.